SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-064026
Filing Date
2024-05-23
Accepted
2024-05-23 17:07:35
Documents
2
Period of Report
2024-05-21

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1538
2 EX-24.1 ivvd-ex24_1.htm EX-24.1 11281
  Complete submission text file 0000950170-24-064026.txt   14384
Mailing Address C/O ACCELERON PHARMA INC. 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
MCLAUGHLIN KEVIN F (Reporting) CIK: 0001214938 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40703 | Film No.: 24979536

Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Issuer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)